http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012003304-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_315ae544538aaeac6d1f4eed6754e4bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b579271496834be1deb916510c5eeb1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2011-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3e58930c4ff9cfb2c22a8e7d8995da |
| publicationDate | 2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2012003304-A1 |
| titleOfInvention | Solid Forms |
| abstract | The present invention is directed to a solid form comprising an active ingredient and croscarmellose, wherein: (i) the croscarmellose has a median particle size of ≧56 microns, (ii) the croscarmellose is present in an amount of ≧4% by weight based on the total weight of the solid form, and (iii) the solid form is a tablet, capsule, caplet, lozenge or granule. The present invention is also directed to a method of decreasing the disintegration time (for example, in water) of a solid form that comprises croscarmellose in an amount ≧4% by weight based on the total weight of the solid form. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016269733-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015334379-A1 |
| priorityDate | 2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 373.